Angel Guan
Angel Guan is a PhD student at Melanoma Institute Australia. Get to know Angel in and out of the lab as she answers questions about herself and her latest work.
Spotlight on our fabulous fundraisers
Read more about what the dedicated and creative fundraisers in our community have done this month to support us - from hair chops and golf days to half marathons, elegant events, Facebook fundraisers and more!
Jesse Brown
Jesse Brown is a PhD student at Melanoma Institute Australia, working at Macquarie University. In this Q&A, we learn about Jesse inside and outside of the lab, from his current projects and future goals to how he spends his downtime.
MIA clinicians & researchers share latest results at ASCO25
Read more about MIA clinicians and researchers in Chicago for ASCO25 - the American Society of Clinical Oncology Annual Meeting - to share latest research and clinical trial results with international colleagues.
Our ‘bench to bedside’ research is saving lives
Read more about our world-leading 'bench to bedside' research cycle, and how you can support it this tax-time, so we can ultimately save ALL lives from melanoma.
Creative and courageous community fundraisers
We recognise our incredible community of fundraisers who continue to amaze us with their courage and creativity. From comedy nights and golf days to marathons, music gigs, Facebook fundraisers and more – they've found unique ways to make a difference.
A magical evening planned for Annual Melanoma Charity Ball
Guests at this year’s Amie St Clair Ball in Wagga Wagga will be welcomed to a ‘Night at the Carnival’ themed evening.
Raising funds and sparking life-saving conversations
Read more about the amazing initiatives organised by our wonderful community, which not only raise critical funds for research, but also generate life-saving awareness.
Addressing fear of cancer recurrence
A study has been released investigating the effectiveness of a Melanoma Care Program for patients with early-stage melanoma with varying degrees of fear of cancer recurrence after treatment of their primary melanoma.